1 2 this Agreement and Attachment 1 (Scope of Services), the terms of this Agreement shall take precedence.Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • California
BETWEENLicense Agreement • August 8th, 2000 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.1 EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement") is made as of February 10, 2003 between Lauren P. Silvernail (the "Executive"), and ISTA Pharmaceuticals, Inc., a Delaware corporation (the "Company")....Executive Employment Agreement • May 15th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
FIRST AMENDMENT TO LEASE (Extended Term) I. PARTIES AND DATE THIS FIRST AMENDMENT TO LEASE (this "Amendment") dated for reference purposes only as of June 27, 2001, is entered into by and between ALTON PLAZA PROPERTY, INC., a Delaware corporation...Lease • April 1st, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 99.5 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO, (ii) AN OPINION OF...Ista Pharmaceuticals Inc • September 25th, 2002 • In vitro & in vivo diagnostic substances • Delaware
ARTICLE I DEFINITIONSRegistration Rights Agreement • January 2nd, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
RECITALSSecurities Purchase Agreement • January 2nd, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
AGREEMENTSupply Agreement • June 4th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Florida
RECITALSLicense Agreement • June 4th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Virginia
UNDERWRITING AGREEMENTIsta Pharmaceuticals Inc • July 14th, 2000 • In vitro & in vivo diagnostic substances • New York
AGREEMENTAgreement • April 5th, 2000 • Ista Pharmaceuticals Inc • California
Exhibit 10.28 ISTA PHARMACEUTICALS, INC. STAND-ALONE STOCK OPTION AGREEMENT -- EARLY EXERCISE I. NOTICE OF STOCK OPTION GRANT VICENTE ANIDO, JR., PH.D. [ADDRESS] You have been granted a Nonstatutory Stock Option to purchase Common Stock of the...Restricted Stock Purchase Agreement • April 1st, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 99.1 MASTER SERVICES AGREEMENT ISTA Pharmaceuticals, Inc. ("ISTA"), located at 15279 Alton Parkway #100 Irvine, California 92692 and R.P. Scherer West, Inc. doing business as SP Pharmaceuticals ("SP"), located at 4272 Balloon Park Road, N.E.,...Master Services Agreement • July 9th, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
2- 3 (g) Waiver of Right of First Offer. Each Major Investor, hereby waives its right of first refusal under the Prior Rights Agreement, including any notice rights pertaining thereto, to purchase the shares of Series D Preferred Stock being issued...Investors Rights Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • California
ANDAsset Purchase and Sale Agreement • May 6th, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
RECITALSNote and Warrant Purchase Agreement • May 14th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
EXHIBIT 10.33 ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT SEPTEMBER 19, 2002 TABLE OF CONTENTSCommon Stock and Warrant Purchase Agreement • May 14th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
ISTA PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • March 6th, 2006 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
This Indemnification Agreement (“Agreement”) is made as of this ___ day of _________, _____, by and between ISTA Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and ____________________ (“Indemnitee”).
ANDPreferred Stock Rights Agreement • January 22nd, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
ISTA PHARMACEUTICALS, INC. AND COMPUTERSHARE TRUST COMPANY, N.A. RIGHTS AGENT PREFERRED STOCK RIGHTS AGREEMENT DATED EFFECTIVE AS OF JANUARY 12, 2012Preferred Stock Rights Agreement • January 17th, 2012 • Ista Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Preferred Stock Rights Agreement is dated effective as of January 12, 2012, between ISTA Pharmaceuticals, Inc., a Delaware corporation, and Computershare Trust Company, N.A., a federally chartered trust company.
AGREEMENT AND PLAN OF MERGER by and among BAUSCH & LOMB INCORPORATED, INGA ACQUISITION CORPORATION and ISTA PHARMACEUTICALS, INC. Dated as of March 26, 2012Agreement and Plan of Merger • March 28th, 2012 • Ista Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is entered into as of March 26, 2012, by and among Bausch & Lomb Incorporated, a New York corporation (the “Parent”), Inga Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of the Parent (“Merger Sub”), and ISTA Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
1 EXHIBIT 10.18 ISTA PHARMACEUTICALS, INC. SERIES D PREFERRED STOCK PURCHASE AGREEMENT Dated March 29, 2000 TABLE OF CONTENTSSeries D Preferred Stock Purchase Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • California
Warrant to Purchase Common Stock of ISTA PHARMACEUTICALS, INC.Ista Pharmaceuticals Inc • September 30th, 2008 • In vitro & in vivo diagnostic substances • New York
[ ] (“[ ]”) intends to transfer Warrants (the “Warrants”) of the Company to (“ ”) without registration under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, we have examined and relied upon the truth of representations contained in an Investor Representation Letter attached hereto and have examined such other documents and issues of law as we have deemed relevant.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 30th, 2008 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 26, 2008, by and between ISTA PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and those lenders set forth on Schedule 1 to the Facility Agreement (as defined below) (individually a “Lender” and together, the “Lenders”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 22nd, 2006 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
• broker-dealers may agree with the selling securityholders to sell a specified number of such shares at a stipulated price per share;
ISTA PHARMACEUTICALS, INC. FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • Delaware
PURCHASE AGREEMENTPurchase Agreement • June 27th, 2007 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
THIS PURCHASE AGREEMENT (this “Agreement”) is made as of the 26th day of June, 2007, by and between ISTA Pharmaceuticals, Inc. (the “Company”), a corporation organized under the laws of the State of Delaware, with its principal offices at 15295 Alton Parkway, Irvine, California 92618, and the purchaser whose name and address is set forth on the signature page hereof (the “Purchaser”).
ISTA PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT UNDER THE Type of Option (check one): ¨ Incentive ¨ NonqualifiedStock Option Agreement • August 31st, 2005 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
This Stock Option Agreement (the “Agreement”) is entered into as of , 200 , by and between ISTA Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (the “Optionee”) pursuant to the Company’s 2004 Performance Incentive Plan, as amended from time to time (the “Plan”). Any capitalized term not defined herein shall have the same meaning ascribed to it in the Plan.
1 EXHIBIT 10.6 CLINICAL DEVELOPMENT AGREEMENT PROTOCOL #VIT-02-08961X AND PROTOCOL #VIT-03-08961X: Two Phase III Safety and Efficacy Studies of Vitrase(TM) (Hyaluronidase for Ophthalmic Intravitreal Injection) for Clearance of Severe Vitreous...Development Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • New Jersey
ISTA PHARMACEUTICALS, INC. RESTRICTED STOCK PURCHASE AGREEMENT UNDER THERestricted Stock Purchase Agreement • August 31st, 2005 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
THIS RESTRICTED STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into as of , 20 by and between (hereinafter referred to as “Purchaser”), and ISTA Pharmaceuticals, Inc., a Delaware corporation (hereinafter referred to as the “Company”), pursuant to the Company’s 2004 Performance Incentive Plan, as amended from time to time (the “Plan”). Any capitalized term not defined herein shall have the same meaning ascribed to it in the Plan.
ISTA PHARMACEUTICALS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENTChange of Control Severance Agreement • March 6th, 2006 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
This Change of Control Severance Agreement (the “Agreement”) is made and entered into effective as of February 20, 2003 (the “Effective Date”), by and between Lauren P. Silvernail (the “Employee”) and ISTA Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 22nd, 2006 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 21, 2006, by and among ISTA Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 15295 Alton Parkway, Irvine, California 92618 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
EXHIBIT 99.2 THIS NOTE AND THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT...Ista Pharmaceuticals Inc • September 25th, 2002 • In vitro & in vivo diagnostic substances • California
PREFERRED STOCK RIGHTS AGREEMENTPreferred Stock Rights Agreement • November 19th, 2002 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • June 16th, 2006 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
This EXCLUSIVE LICENSE AGREEMENT (hereinafter called this “Agreement”) is made and effective as of the 12th of June, 2006 by and between:
